Vibrant nets $15m and 14 more deal updates from Greater China worth over $470m

Vibrant Therapeutics, an AI-driven macromolecular drug discovery and development platform, has completed raising 100 million yuan ($15 million) in a new funding round.

Matrix Partners China has led the funding with the participation of Sequoia Capital China alongside existing backer Redhill Capital.

CEC Capital served as the financial advisor for the deal.

Vibrant will invest the proceeds to accelerate the R&D of macromolecular drugs, technology innovation, and talent management.

Vibrant, which was established in 2019 by Larry Wang (the founder of biotech major GenScript), utilizes AI technologies and biotechnologies such as deep learning, bioinformatics and immunology to develop macromolecular drugs.

The Guangzhou-headquartered focuses on the oncology sector.

Prior to that, in 2020, Redhill Capital had exclusively backed Vibrant’s angel round.

CHINA DEAL MONITOR

DealStreetAsia has also put together a table listing out all prominent venture capital transactions in the Greater China region on January 12 – 13, 2022. 

Expand Table

StartupHeadquarterInvestment Size (USD)Investment StageLead Investor(s)Other Investor(s)Verticals
Shanghai Eigencomm TechnologiesShanghai`157 million CSoftBank Vision Fund 2Cathay Capital, CoStone Capital, GF Qianhe, Chobe Capital, Qiming Venture Partners, Fellow Partners, Xingwang Investment, China Universal Asset Management 5G
Shanghai ZhenGe Biotechnology Shanghai100 milion CGoldman Sachs Asset Management, SofinaNovo Holdings A/S, Qiming Venture Partners, IDG Capital, Lyfe Capital, GT Capital, Cowin CapitalHealthTech
Zhejiang EVTECH Hangzhou47 millionStrategy, DD:Huaqiang Capital Strategy: Hubei Xiaomi Changjiang Industry Fund; D: CR MICRO, Hongda High-Tech HoldingElectric/Hybrid Vehicles
WAYTOUSBeijing 47 millionCCICC-SAIC Industry FundYuexiu Fund, BHCPAutonomous Driving
Tinychip Shanghai47 millionA+Summitview CapitalFengyuan Fund, Xinyuxing Fund, Oceanpine Capital N/A
Westlake OmicsHangzhou* 15 millionPre-AEfund Capital, GL VenturesGaorong Capital, Med-Fine Capital, XHVCBiotech
Jiangsu Guanhuai Medical Suzhou* 15 millionBSherpa Healthcare Partners, BioTrack CapitalCoStone Capital, Wuzhong Biopharmaceutical Industry FundHealthTech
Vibrant TherapeuticsGuangzhou 15 million-Matrix Partners China Sequoia Capital China, Redhill Capital HealthTech
MKSemiShanghai13 million Pre-A+Lightspeed China Partners, Gaorong CapitalQiming Venture Partners, Ivy Capital Internet of Things
ChuangkitBeijing * 10 millionB-Kingsoft Office, Gobi ChinaCloud Computing
Rotex IncZhuhai* 1.5 millionAAlwin Capital GL Ventures, Hannan Mangao, Jiangsu Hailai Xinchuang Medical TechnologyHealthTech
Beijing Qiaohe Sunmao Culture Technology Beijing * 1.5 millionAngel -Plum Ventures, Red Book N/A
yunwujie.comShenzhen* 1.5 millionStratgy -Hejun Capital, Baohengfeng InvestmentE-commerce
Black Sesame TechnologiesShanghai-Stratgy -Boyuan Capital AI and Machine Learning
DengLin TechnologiesShanghai-Stratgy -Qualcomm Ventures, Forebright Capital, Lizi Weilai, Qingling Huayu, Silicon Harbour Capital, Qianhui ZhitouAI and Machine Learning

indicates that the company did not provide the specific size of the deal but only a range. So, we adopted the smallest number in the range, which is “10 million yuan ($1.5 million)” in the given example. 

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.